Results 51 to 60 of about 15,353 (195)

Laryngeal Cryotherapy for Neurogenic Cough: Safety, Feasibility, and Prospective Outcomes

The Laryngoscope, EarlyView.
A prospective clinical trial investigated the safety and clinical outcomes of office‐based selective laryngeal cryotherapy for patients with refractory chronic cough. Patient were followed for 6 months posttreatment and had durable improvement in cough severity index and urge‐to‐cough scores and no serious long term adverse effects.
Shumon I. Dhar, Eric Allen, Yun‐Lun Liu, Alexandra D. D'Oto, Rishi Suresh, Adrianna Shembel, Ted Mau   +6 more
wiley   +1 more source

Vocal Outcomes After Cell‐Based Outer Vocal Fold Implant in Porcine Bilateral Vocal Fold Resection

The Laryngoscope, EarlyView.
Cell‐based outer vocal fold replacement (COVR) was evaluated in a porcine model of bilateral vocal fold injury using longitudinal acoustic analysis and histologic assessment. COVR implantation resulted in recovery of the nonperiodic acoustic parameter Q50 to preoperative levels by 6 months, with implanted human adipose‐derived stem cells detected in 7 ...
Keer Zhang, Georgia Crane, Mateo Ruiz Alvarez, Alexandra Klomhaus, Yazeed Alhiyari, Bhavani Gowda, Michael Döllinger, Jennifer Long   +7 more
wiley   +1 more source

Outcomes of Recurrent Laryngeal Nerve Reinnervation for Pediatric Unilateral Vocal Fold Paralysis

The Laryngoscope, EarlyView.
The objective of this study was to describe voice outcomes from the largest single‐center, single‐surgeon experience with recurrent laryngeal nerve reinnervation for pediatric unilateral vocal fold paralysis. In 102 patients who underwent reinnervation, we demonstrate that reinnervation is an effective and durable intervention for treatment of ...
Theodore A. Gobillot, Linda M. Carroll, Karen B. Zur   +2 more
wiley   +1 more source

Comprehensive pharmaco-neurological treatment of dysphonia as a result of cervical spine pathology

Лечащий Врач
Background. Currently, there is a gradual increase in the number of cases of dysphonia. In individuals whose professional activities involve significant vocal strain, such as teachers, singers, etc., dysphonia may occur 1.4 times more frequently than in ...
D. A. Shakurova, I. V. Soloveva
doaj   +1 more source

Vocal Fold Atrophy in Patients With Alzheimer's Disease and Related Dementias

The Laryngoscope, EarlyView.
This is the first study to quantify vocal fold atrophy in patients with Alzheimer's disease and related dementias (AD/ADRD) using endoscopic imaging. Compared with age‐matched controls, AD/ADRD patients showed significantly greater vocal fold bowing and reduced mucosal wave amplitude, while normalized glottal gap area did not differ.
Byron Kim, Carson Miller, Shruti Dhingra, Mahdi Al‐Ghezi, Emily Wilson, Neel K. Bhatt   +5 more
wiley   +1 more source

Cervical Inlet Patches in R‐CPD: An Unrecognized Predictor of Treatment Failure

The Laryngoscope, EarlyView.
This retrospective cohort study identified cervical inlet patches (CIP) in 19.8% of patients undergoing cricopharyngeal botulinum toxin injection for R‐CPD. CIP presence and increasing age independently predicted failure to sustain a long‐term treatment response, suggesting that CIP may be an underrecognized factor in R‐CPD treatment durability ...
Andrew Geoffrey Tritter, Nabeeha Hasan, Jered Wilson   +2 more
wiley   +1 more source

Association of Glucagon‐Like Peptide—1 Receptor Analogues and Laryngeal Symptoms in Obese Adults

The Laryngoscope, EarlyView.
Table 1 succinctly quantifies the time‑dependent association between GLP‑1RA/GIP therapy and laryngeal symptoms, demonstrating modest but statistically robust increases in outcomes such as cough and voice/resonance disorders by 6 months. It provides clinically actionable absolute risks, odds ratios, and hazard ratios that can directly inform counseling,
Priyanka Shah, David Kayekjian, Shaun A. Nguyen, Kirsten Meenan, Ashli K. O’Rourke   +4 more
wiley   +1 more source

Case report: Dysphonia associated with high-dose cytarabine therapy

Frontiers in Pharmacology
Cytarabine is widely used in the treatment of hematological malignancies. Its common toxicities include myelosuppression and gastrointestinal disturbances. Additionally, it can cause central nervous system (CNS) symptoms, which include hoarseness, ataxic
Ling Ma, Niya Huang, Haixi Zhang, Jia Liu, Zhiqing Zhang   +4 more
doaj   +1 more source

Voice changes in patients with chronic obstructive pulmonary disease

Egyptian Journal of Chest Disease and Tuberculosis, 2014
Introduction: Voice changes are not a direct symptom of chronic obstructive pulmonary disease (COPD), but many COPD patients experience voice changes.
Enas Elsayed Mohamed, Riham Ali El maghraby   +1 more
doaj   +1 more source

Pitch Strength & Percent Vocal Creak to Assess Treatment Response in Adductor Laryngeal Dystonia

The Laryngoscope, EarlyView.
Pitch Strength (PS) and Percent Vocal Creak (%VC) were measured before and after botulinum neurotoxin treatment in patients with adductor laryngeal dystonia (AdLD). While PS and %VC correlated with changes in disruption frequency and perceptual severity, they did not demonstrate robust group‐level treatment sensitivity.
Jesse D. Hoffmeister, Maisie K. Simpson, Joseph Hayek, Scott Lunos, Stephanie Misono, Jürgen Konczak   +5 more
wiley   +1 more source